The role of the thalamus in the pathogenesis of the visual and auditory hallucinations has been reported under the name of peduncular hallucinosis, usually with coexisting midbrain involvement. These hallucinations typically take the form of dreamy de novo productions (phanteidolias), less often that of transformations of perceptions into new items (such as seeing faces in clouds) called pareidolias. However, hallucinations taking the form of a complex distortion of perception is a different phenomenon, which to our knowledge has not been reported. We studied 2 patients with complex, ‘fantastic', perceptive distortion involving the visual and auditory systems after thalamic stroke limited to the region of the dorsomedial nucleus, sparing the intralaminar nuclei and the midbrain (explaining the lack of disorders of consciousness and confusional state). Our patients reported the modification of usual stimuli (face, body, voices) into unreal, fantastically distorted perceptions (monstrous change of shapes or sounds without appearance of new items). While the exact mechanism leading to such perceptive distortions remains unknown, a release phenomenon due to damage to the dorsomedial thalamus (probably affecting cholinergic system) responsible for a disinhibition of cortical function involved in familiarity of perception seems likely. We suggest that these hallucinations should be called ‘distorteidolias'.

1.
Lhermitte J: Syndrome de la calotte du pédoncule cérébral. Les troubles psycho-sensoriels dans les lésions du mésencéphale. Rev Neurol (Paris) 1922;2:1359-1365.
2.
Van Bogaert L: L'hallucinose pédonculaire. Rev Neurol 1927;47:408-417.
3.
Feinberg WM, Rapcsak SZ: Peduncular hallucinosis following paramedian thalamic infarction. Neurology 1989;39:1535-1536.
4.
Tatu L, Moulin T, Chavot D, Berges S, Chopard J-L, Rumbach L: Hallucinations et infarctus thalamique. Rev Neurol 1996;152:557-559.
5.
Kölmer HW: Peduncular hallucinations. J Neurol 1991;238:457-459.
6.
Arboix A, García-Plata C, García-Eroles L, Massons J, Comes E, Oliveres M, Targa C: Clinical study of 99 patients with pure sensory stroke. J Neurol 2005;252:156-162.
7.
Noda S, Mizoguchi M, Yamamoto A: Thalamic experiential hallucinosis. J Neurol Neurosurg Psychiatriy 1993;56:1224-1226.
8.
Inzelberg R, Vishniesvskaya S, Korczyn AD: Transient musical hallucinosis. J Neurol Neurosurg Psychiatry 1993;56:833.
9.
Serra Catafau J, Rubio F, Peres Serra J: Peduncular hallucinosis associated with posterior thalamic infarction. J Neurol 1992;239:89-90.
10.
Danziger N, Meary E, Mercier B, Samson Y, Rancurel G: Hallucinose visuelle et hyperhédonisme au cours d'un infarctus pontique et thalamique. Rev Neurol 1997;153:11, 679-683.
11.
Lee S, Kim DY, Kim JS, Kaur G, Lippmann S: Visual hallucinations following a left-sided unilateral tuberothalamic artery infarction. Innov Clin Neurosci 2011;8:31-34.
12.
Carrera E, Bogousslavsky J: The thalamus and behavior. Neurology 2006;66:1817-1823.
13.
Manford M, Andermann F: Complex visual hallucinations. Clinical and neurobiological insights. Brain 1998;121:1819-1840.
14.
Uchiyama M, Nishio Y, Yokoi K, Hirayama K, Imamura T, Shimomura T, Mori E: Pareidolias: complex visual illusions in dementia with Lewy bodies. Brain 2012;135:2458-2469.
15.
Shin S, Lee JE, Hong JY, Sunwoo MK, Sohn YH, Lee PH: Neuroanatomical substrates of visual hallucinations in patients with non-demented Parkinson's disease. J Neurol Neurosurg Psychiatry 2012;83:1155-1161.
16.
Janzen J, van Ent D, Lemstra AW, Berendse HW, Barkhof F, Foncke EM: The pedunculopontine nucleus is related to visual hallucinations in Parkinson's disease: preliminary results of a voxel-based morphometry study. J Neurol 2012;259:147-154.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.